NCT01691014 Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents Status TERMINATED Phase N/A
NCT01690351 A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted State Status COMPLETED Phase PHASE1
NCT01689207 To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) Status COMPLETED Phase PHASE1
NCT01687673 Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT01684215 A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT01680458 Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication Status COMPLETED Phase N/A
NCT01679119 Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy Status COMPLETED Phase PHASE2
NCT01677065 A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers Status COMPLETED Phase N/A
NCT01677039 Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation Status COMPLETED Phase PHASE1
NCT01673178 Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT01672645 A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers. Status COMPLETED Phase PHASE1
NCT01671280 Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) Status COMPLETED Phase N/A
NCT01664923 Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer Status COMPLETED Phase PHASE2
NCT01664065 A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy Subjects Status COMPLETED Phase PHASE1
NCT01663220 Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT01663207 Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes Status COMPLETED Phase N/A
NCT01660334 Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan) Status COMPLETED Phase N/A